Your English writing platform
Discover LudwigSuggestions(1)
Exact(3)
Numerous agents targeting angiogenesis are currently being explored.
- Numerous agents targeting mTOR, PI-3K, growth factor receptors, and related tyrosine kinases, Ras, Raf, and B-Raf, S6K, MEK1/2 have been tested to treat cancer.
Various trials have been performed to assess individualized drugs for the treatment of cancer that target the patients' individual genetic makeup, and numerous agents targeting various cancer-related proteins have recently been developed.
Similar(57)
Numerous agents specifically targeting dysregulated molecular pathways, believed to be key tumorigenic drivers, have recently been approved or are being evaluated as potential treatment options in patients with breast cancer or other tumor types [ 19].
Numerous studies have suggested that pharmacological agents targeting either of these pathways may produce an improvement in histological and functional outcome measures.
☑ Strong synergy has been observed between the numerous inhibitors targeting hepatitis C virus (HCV) entry and antiviral agents targeting other stages of the HCV lifecycle.
Recently, various molecular agents targeting the PI3-kinase/PTEN/Akt pathway have been developed including mTOR inhibitors such as everolimus and temsirolimus, and numerous clinical studies are ongoing in endometrial cancer (Oza et al, 2011).
Biological agents targeting inflammatory cytokines such as TNF-α have widely used in recent years as effective medications for treating AS, while numerous cases of the appearance of malignant tumors in patients receiving these drugs have been reported [ 20].
Agents targeting the programmed death 1 (PD-1) pathway, either PD-1 or one of its ligands, programmed death ligand 1, are in active clinical development for numerous cancers, including advanced melanoma and lung cancer.
Alterations in Bcl2 family proteins commonly mediate this, so numerous agents that target Bcl2 family activities are in clinical development.
It is not known if American agents targeted the casinos.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com